Introducing BioVision's New GeneGlide™ Transfection Reagents!

Introducing BioVision's New GeneGlide™ Transfection Reagents!

FOR IMMEDIATE RELEASE

MILPITAS, Calif. - May 10, 2016 - PRLog -- BioVision proudly announces the launch of GeneGlideTM Transfection Reagents that are ideal for delivering nucleic acids including DNA, siRNA, miRNA to mammalian cells. Each of the reagents are highly efficient, yet exhibiting lower cellular toxicity and can be used for a wide variety of cell types. Additionally, we also offer fluorescently labeled RNAi duplexes as transfection delivery controls.

Product Types:
·  GeneGlide™ DNA Transfection Reagent
·  GeneGlide™ siRNA Transfection Reagent
·  GeneGlide™ siRNA Delivery Control

Key Features:
•  For Stable and Transient Transfections
•  Broad Spectrum Delivery Types Including Hard-to-Transfect Cell Lines and Primary Cells
•  Low Cellular Toxicity
•  High Efficiency Delivery
•  Serum Compatible
•  Reproducible Results and Reduction in Experimental Bias


For more information on our Molecular Biology Tools, please Visit the following link:
http://www.biovision.com/search/results.html?keywords=transfection&x=0&y=0

About BioVision:

BioVision, Inc. is a privately held Life Science company headquartered in the beautiful San Francisco Bay area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, and more.

« Back
$
Subscribe to our Newsletter!!
and automatically get enrolled into a raffle to win Google Home.
Offer valid for US customers only.